Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke

Early reperfusion therapy with tissue plasminogen activator (tPA) for acute ischemic stroke has mortality benefits despite the risks. Myocardial infarction (MI) after the use of thrombolytic therapy is a rare complication. We report a 67-year-old woman with acute stroke who received tPA for acute is...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohmand, Billal, Naqvi, Abeeha, Singh, Avneet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388234/
https://www.ncbi.nlm.nih.gov/pubmed/34462690
http://dx.doi.org/10.7759/cureus.16659
_version_ 1783742602850336768
author Mohmand, Billal
Naqvi, Abeeha
Singh, Avneet
author_facet Mohmand, Billal
Naqvi, Abeeha
Singh, Avneet
author_sort Mohmand, Billal
collection PubMed
description Early reperfusion therapy with tissue plasminogen activator (tPA) for acute ischemic stroke has mortality benefits despite the risks. Myocardial infarction (MI) after the use of thrombolytic therapy is a rare complication. We report a 67-year-old woman with acute stroke who received tPA for acute ischemic stroke and subsequently developed ST elevation MI (STEMI), highlighting a rare and serious complication. 
format Online
Article
Text
id pubmed-8388234
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-83882342021-08-29 Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke Mohmand, Billal Naqvi, Abeeha Singh, Avneet Cureus Cardiology Early reperfusion therapy with tissue plasminogen activator (tPA) for acute ischemic stroke has mortality benefits despite the risks. Myocardial infarction (MI) after the use of thrombolytic therapy is a rare complication. We report a 67-year-old woman with acute stroke who received tPA for acute ischemic stroke and subsequently developed ST elevation MI (STEMI), highlighting a rare and serious complication.  Cureus 2021-07-27 /pmc/articles/PMC8388234/ /pubmed/34462690 http://dx.doi.org/10.7759/cureus.16659 Text en Copyright © 2021, Mohmand et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Mohmand, Billal
Naqvi, Abeeha
Singh, Avneet
Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
title Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
title_full Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
title_fullStr Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
title_full_unstemmed Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
title_short Paradoxical Myocardial Infarction After Thrombolytic Therapy for Acute Ischemic Stroke
title_sort paradoxical myocardial infarction after thrombolytic therapy for acute ischemic stroke
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388234/
https://www.ncbi.nlm.nih.gov/pubmed/34462690
http://dx.doi.org/10.7759/cureus.16659
work_keys_str_mv AT mohmandbillal paradoxicalmyocardialinfarctionafterthrombolytictherapyforacuteischemicstroke
AT naqviabeeha paradoxicalmyocardialinfarctionafterthrombolytictherapyforacuteischemicstroke
AT singhavneet paradoxicalmyocardialinfarctionafterthrombolytictherapyforacuteischemicstroke

Ejemplares similares